Retatrutide is a new treatment in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in research studies. By stimulating these receptors, https://pennyovtf935234.blogdemls.com/36061639/tirzepatide-a-promising-new-treatment-for-obesity